Zobrazeno 1 - 10
of 31
pro vyhledávání: '"R N, DuBois"'
Autor:
O. Margalit, R. N. DuBois, Murali Ravoori, Sanjaya Singh, Vikas Kundra, David G. Menter, Sun-Hee Kim, Wei Wei
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Quantifying tumor burden is important for following the natural history of orthotopic colon cancer and therapeutic efficacy. Bioluminescence imaging (BLI) is commonly used for such assessment and has both advantages and limitations. We compared BLI a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65cb7625e98f83a2f2bd734ea893a7f
https://pubmed.ncbi.nlm.nih.gov/30988343
https://pubmed.ncbi.nlm.nih.gov/30988343
Autor:
R. N. Dubois
Publikováno v:
Alimentary Pharmacology & Therapeutics. 14:64-67
Summary Use of nonsteroidal anti-inflammatory drugs such as aspirin, which are known to inhibit cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50%. Animal and human studies have shown a 50–80% reduction in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f7cde4ded296d4e15487f6204b9a76
https://doi.org/10.1046/j.1365-2036.2000.014s1064.x
https://doi.org/10.1046/j.1365-2036.2000.014s1064.x
Autor:
H M, Kandil, R N, Dubois
Publikováno v:
Methods in molecular medicine. 50
Most epidemiological studies (1-7) support a protective role of aspirin and nonsteroidal antiinflammatory drugs (NSAIDs) against colorectal cancer. People who (by their report) take aspirin regularly have about a 50% decrease in the incidence (3,4) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4b797c4ed8c237e652d49b7772d4ce4
https://pubmed.ncbi.nlm.nih.gov/21318829
https://pubmed.ncbi.nlm.nih.gov/21318829
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(10)
It has been proposed that Cyclooxygenase (COX)-2 inhibitors may be able to enhance the effects of chemotherapeutic or radiation treatment; however, currently few studies have been reported that define the radiation-enhancing effect of COX-2 inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::190fb64506ba40a85a820b2344585891
https://pubmed.ncbi.nlm.nih.gov/11595687
https://pubmed.ncbi.nlm.nih.gov/11595687
Autor:
J M, Kurie, R N, Dubois
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e54fdb5f83bd201c4d52946da4a90211
https://pubmed.ncbi.nlm.nih.gov/11555578
https://pubmed.ncbi.nlm.nih.gov/11555578
Publikováno v:
Digestive diseases and sciences. 46(4)
Barrett's epithelium is a recognized premalignant condition for esophageal adenocarcinoma. Nonsteroidal antiinflammatory drugs (NSAIDs) decrease the relative risk of colon cancer in humans and the esophageal tumor load in carcinogen-treated mice. Pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d0bd619412ef50db64f880460cbfd77
https://pubmed.ncbi.nlm.nih.gov/11330414
https://pubmed.ncbi.nlm.nih.gov/11330414
Publikováno v:
Cancer research. 61(6)
Cyclooxygenase (COX) 2 expression is regulated via the Ras signaling pathway, and induction of mutated Ras rapidly increases COX-2 levels in intestinal epithelial cells. Protein kinase B (Akt/PKB) is an important effector of Ras signaling and a criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a90267887857bbe0f1f18b8b45330fed
https://pubmed.ncbi.nlm.nih.gov/11289146
https://pubmed.ncbi.nlm.nih.gov/11289146
Publikováno v:
Cancer research. 60(21)
Nonsteroidal anti-inflammatory drugs have potential for use in the prevention and/or treatment of colorectal cancer. We have studied the cytotoxic effect of a specific COX-2 inhibitor, celecoxib, against LLC, HCA-7, and HCT-15 cells grown in cell cul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::001bbd07c2c0a917829d2d0439e39d17
https://pubmed.ncbi.nlm.nih.gov/11085526
https://pubmed.ncbi.nlm.nih.gov/11085526
Autor:
P E, Lipsky, S B, Abramson, F C, Breedveld, P, Brook, R, Burmester, F, Buttgereit, G W, Cannon, F, Catella-Lawson, L J, Crofford, M, Doherty, M, Dougados, R N, DuBois, J, Froelich, L A, Garcia Rodriguez, A, Gibofsky, S, Hernandez-Diaz, M C, Hochberg, A, Krause, M H, Liang, K, Machold, P M, Peloso, L G, Raisz, B, Schayes, J M, Scheiman, L S, Simon, J, Smolen
Publikováno v:
The Journal of rheumatology. 27(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f692624e177ca1b2958d925142ce067b
https://pubmed.ncbi.nlm.nih.gov/10852251
https://pubmed.ncbi.nlm.nih.gov/10852251
Autor:
R N, Dubois
Publikováno v:
Alimentary pharmacologytherapeutics. 14
Use of nonsteroidal anti-inflammatory drugs such as aspirin, which are known to inhibit cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50%. Animal and human studies have shown a 50-80% reduction in tumour mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2ec69c39b1bf7c371860f176a765fb4
https://pubmed.ncbi.nlm.nih.gov/10807405
https://pubmed.ncbi.nlm.nih.gov/10807405